BioAdaptives, Inc.
BDPT · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 43.9% | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 83.1% | 33% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -6,235.9% | -4,574.9% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -8,193% | -4,905.7% | – | – |
| EPS Diluted | -0.04 | -0.017 | -0.022 | -0.038 |
| % Growth | -141% | 23.9% | 41.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |